Neoadjuvant Trial of Lapatinib for the Treatment of Women With DCIS Breast Cancer

Trial Profile

Neoadjuvant Trial of Lapatinib for the Treatment of Women With DCIS Breast Cancer

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Lapatinib (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms LAPIS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top